GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Kuros Biosciences Ltd (XSWX:KURN) » Definitions » Other Current Liabilities

Kuros Biosciences (XSWX:KURN) Other Current Liabilities : CHF11.31 Mil (As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Kuros Biosciences Other Current Liabilities?

Kuros Biosciences's other current liabilities for the quarter that ended in Dec. 2023 was CHF11.31 Mil.

Kuros Biosciences's quarterly other current liabilities declined from Dec. 2022 (CHF10.87 Mil) to Jun. 2023 (CHF10.24 Mil) but then increased from Jun. 2023 (CHF10.24 Mil) to Dec. 2023 (CHF11.31 Mil).

Kuros Biosciences's annual other current liabilities increased from Dec. 2021 (CHF10.13 Mil) to Dec. 2022 (CHF10.87 Mil) and increased from Dec. 2022 (CHF10.87 Mil) to Dec. 2023 (CHF11.31 Mil).

Kuros Biosciences Other Current Liabilities Historical Data

The historical data trend for Kuros Biosciences's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kuros Biosciences Other Current Liabilities Chart

Kuros Biosciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Kuros Biosciences Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Kuros Biosciences Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Kuros Biosciences Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Kuros Biosciences's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Kuros Biosciences (XSWX:KURN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Kuros Biosciences Ltd (XSWX:KURN) » Definitions » Other Current Liabilities
Comparable Companies
XSWX:MED TSE:5212 ABT SYK MDT BSX EW DXCM SZSE:300760 ZBH ALGN STE XAMS:PHIA XSWX:SOON SHSE:688271 ASX:COH BRKR SWAV PODD OCSE:DEMANT
Traded in Other Exchanges
CSBTF:USA KURNz:UK
Address
Wagistrasse 25, Schlieren, Zurich, CHE, 8952
Website
https://www.kurosbio.com
Kuros Biosciences Ltd is a Swiss-based biopharmaceutical company focused on the development of innovative products for tissue repair and bone regeneration. It operates through the following segments: Medical devices, Pharmaceuticals and Legacy portfolio. The Medical devices segment includes products such as MagnetOs and Attrax. The Pharmaceuticals segment includes products such as Fibrin-PTH, a drug-biologic combination that promotes targeted and controlled bone formation through the induction of osteoprogenitor cell differentiation, enhancement, of osteoblast proliferation and increasing the lifespan of bone-forming cells. The Legacy portfolio segment includes all other products that do not belong to the group's core business strategy.

Kuros Biosciences (XSWX:KURN) Headlines

No Headlines